Risultati della ricerca - Greuter, Marjolein J E
- Mostra 1 - 11 risultati su 11
-
1
Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program di Vleugels, Jasper L. A., Greuter, Marjolein J. E., Hazewinkel, Yark, Coupé, Veerle M. H., Dekker, Evelien
Pubblicazione 2017testo -
2
-
3
Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening di Bronzwaer, Maxime E. S., Greuter, Marjolein J. E., Bleijenberg, Arne G. C., IJspeert, Joep E. G., Dekker, Evelien, Coupé, Veerle M. H.
Pubblicazione 2018testo -
4
Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients di Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Pubblicazione 2020testo -
5
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients di Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Pubblicazione 2021testo -
6
-
7
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data di Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.
Pubblicazione 2019testo -
8
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study di Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Twisk, Jos W. R., Koopman, Miriam, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Pubblicazione 2021testo -
9
Early cost-effectiveness analysis of risk-based selection strategies for adjuvant treatment in stage II colon cancer: the potential value of prognostic molecular markers di Jongeneel, Gabrielle, Greuter, Marjolein J.E., Kunst, Natalia, van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Vermeulen, Louis, Ijzermans, Jan N.M., Vink, Geraldine R., Punt, Cornelis J.A., Coupé, Veerle M.H.
Pubblicazione 2021testo -
10
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study di van Wifferen, Francine, de Jonge, Lucie, Worthington, Joachim, Greuter, Marjolein J.E., Lew, Jie-Bin, Nadeau, Claude, van den Puttelaar, Rosita, Feletto, Eleonora, Yong, Jean H.E., Lansdorp-Vogelaar, Iris, Canfell, Karen, Coupé, Veerle M.H.
Pubblicazione 2022testo -
11
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) di Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Kandimalla, Raju, Goel, Ajay, Bujanda, Luis, Meijer, Gerrit A., Fijneman, Remond J. A., van Oijen, Martijn G. H., Ijzermans, Jan, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Pubblicazione 2020testo